Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the insulin pens, syringes, pumps and injectors market grown in recent years?

The market for insulin pens, syringes, pumps, and injectors has seen swift expansion in recent years. It is projected to intensify from a value of $21.6 billion in 2024 to $24.26 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 12.3%. The historical period’s expansion can be linked to urban development and infrastructure growth, rural electrification, industrialization, and the incorporation of renewable energy.

How is the insulin pens, syringes, pumps and injectors market size expected to evolve during the forecast period?

The market for insulin pens, syringes, pumps, and injectors is forecasted to experience a significant increase in size in the coming years, expanding to a value of $37.86 billion by 2029, with a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this anticipated growth include advancements in energy transition, the electrification of transport systems, the development of smart grids and integration of the internet of things (IoT), expansion of 5G technology, and replacement of outdated infrastructure. Noteworthy future trends consist of the adoption of high-voltage direct current (hvdc) cables, fire-resistant insulation materials, incorporation of fiber optics, eco-friendly materials, and an emphasis on customization and specialization.

Get your insulin pens, syringes, pumps and injectors market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp

Which key drivers are propelling the insulin pens, syringes, pumps and injectors market’s growth?

The global rise in diabetes is propelling the expansion of the market for insulin pens, syringes, pumps, and injectors. Diabetes is a chronic condition characterized by the body’s inability to efficiently regulate blood sugar due to inadequate insulin production or inefficient insulin use, leading to elevated blood sugar levels. Factors such as the increasing prevalence of obesity, poor dietary choices, lack of physical activity, and the growing elderly population are contributing to the worldwide increase in diabetes cases. This surge in diabetes is stimulating the insulin delivery devices market’s growth, as more people require insulin pens, syringes, pumps, and injectors for effective and manageable care. For example, a report published by the International Diabetes Federation, which is a Belgium-based collective of over 240 national diabetes associations, revealed that around 537 million adults globally were living with diabetes in 2021, a number that is expected to reach 783 million by 2045. As a result, the global increase in diabetes prevalence is driving the expansion of the insulin pens, syringes, pumps, and injectors market.

What are the market segments in the insulin pens, syringes, pumps and injectors industry?

The insulin pens, syringes, pumps and injectors market covered in this report is segmented –

1) By Type: Pens, Injectors And Pumps, Syringes

2) By Pens: Reusable, Disposable

3) By Pumps: Tubed Pumps, Tubeless Pumps

4) By End Users: Hospitals, Homecare, Other End Users

Subsegments:

1) By Pens: Disposable Insulin Pens, Reusable Insulin Pens

2) By Injectors And Pumps: Insulin Injectors, Insulin Pumps, Traditional Insulin Pumps, Patch Insulin Pumps

3) By Syringes: Disposable Syringes, Reusable Syringes

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp

Which leading companies are shaping the growth of the insulin pens, syringes, pumps and injectors market?

Major companies operating in the insulin pens, syringes, pumps and injectors market include Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.

What key trends are currently impacting the insulin pens, syringes, pumps and injectors market’s development?

A multitude of businesses within the insulin pens, syringes, pumps, and injectors market are concentrating on enhancing technology within insulin delivery systems for effective and safe insulin distribution. These systems, including pens, syringes, pumps, and injectors, are engineered to provide diabetics with insulin, enabling accurate and efficient control of blood sugar levels. For example, in June 2024, Insulet Corporation, a medical equipment manufacturer from the United States, introduced Omnipod 5. This tubeless automated insulin delivery system is designed for individuals with type 1 diabetes who are two years and older. Notably, it is the first system that can integrate with both the Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitors, providing unparalleled compatibility with these top-tier CGM brands for superior diabetes management.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3806

Which geographic areas are influencing the growth of the insulin pens, syringes, pumps and injectors market?

North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Blood Glucose Meters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: